Hypoglycaemia in diabetes mellitus: Epidemiology and clinical implications

Nature Reviews Endocrinology

Volumn 10, Issue 12, 2014, Pages 711-722

  Frier, Brian M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; ANTIDIABETIC AGENT;

BLOOD GLUCOSE MONITORING; BLOOD RHEOLOGY; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; COGNITIVE DEFECT; COMA; DIET; ELECTROENCEPHALOGRAM; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEMOSTASIS; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PATIENT EDUCATION; PRIORITY JOURNAL; REVIEW; SEIZURE; AMBULATORY MONITORING; ARRHYTHMIAS, CARDIAC; ARTIFICIAL PANCREAS; CHEMICALLY INDUCED; COGNITION DISORDERS; DIABETES MELLITUS; INSULIN INFUSION; MYOCARDIAL ISCHEMIA;

ARRHYTHMIAS, CARDIAC; BRAIN ISCHEMIA; COGNITION DISORDERS; DIABETES MELLITUS; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MONITORING, AMBULATORY; MYOCARDIAL ISCHEMIA; PANCREAS, ARTIFICIAL;

EID: 84927178554     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2014.170     Document Type: Review

References (128)

1. Strachan, M. W. J. in Hypoglycaemia in Clinical Diabetes 3rd edn Ch. 4 (eds Frier, B. M., Heller, S. R. & McCrimmon, R. J.) 63-95 (Wiley Blackwell, 2014).
2. Pramming, S., Thorsteinsson, B., Bendtson, I. & Binder, C. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet. Med. 8, 217-222 (1991).
3. Akram, K., Pedersen-Bjergaard, U., Carstensen, B., Borch-Johnsen, K. & Thorsteinsson, B. Frequency and risk factors of severe hypoglycaemia in insulin-treated type 2 diabetes: a cross-sectional survey. Diabet. Med. 23, 750-756 (2006).
4. Jørgensen, H., Pedersen-Bjergaard, U., Rasmussen, A. & Borch-Johnsen, K. The impact of severe hypoglycemia and impaired awareness of hypoglycemia on relatives of patients with type 1 diabetes. Diabetes Care 26, 1106-1109 (2003).
5. Schopman, J. E. & DeVries, J. H. in Hypoglycaemia in Clinical Diabetes 3rd edn Ch. 9 (eds Frier, B. M., Heller, S. R. & McCrimmon, R. J.) 184-196 (Wiley Blackwell, 2014).
6. McGowan, K., Thomas, W. & Moran, A. Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes. Diabetes Care 25, 1499-1503 (2002).
7. Pedersen-Bjergaard, U. et al. Severe hypoglycaemia in 1,076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab. Res. Rev. 20, 479-486 (2004).
8. Donnelly, L. A. et al. Frequency and predictors of hypoglycaemia in type 1 and insulin-treated type 2 diabetes: a population-based study. Diabet. Med. 22, 749-755 (2005).
9. Ostenson, C. G. et al. Self-reported non-severe hypoglycaemic events in Europe. Diabet. Med. 31, 92-101 (2014).
10. Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 28, 1245-1249 (2005).
11. Frier, B. M. Defining hypoglycaemia: what level has clinical relevance? Diabetologia 52, 31-34 (2009).
12. Cryer, P. E. Preventing hypoglycaemia: what is the appropriate glucose alert value? Diabetologia 52, 35-37 (2009).
13. Swinnen, S. G., Mullins, P., Miller, M., Hoekstra, J. B. & Holleman, F. Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemia. Diabetologia 52, 38-41 (2009).
14. Bulsara, M. K., Holman, C. D., Davis, E. A. & Jones, T. W. Evaluating risk factors associated with severe hypoglycaemia in epidemiology studies-what method should we use? Diabet. Med. 21, 914-919 (2004).
15. Cox, D. J. et al. Frequency of severe hypoglycemia in insulin-dependent diabetes mellitus can be predicted from self-monitoring blood glucose data. J. Clin. Endocrinol. Metab. 79, 1659-1662 (1994).
16. Kilpatrick, E. S., Rigby, A. S., Goode, K. & Atkin, S. L. Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes. Diabetologia 50, 2553-2561 (2007).
17. Monnier, L., Wojtusciszyn, A., Colette, C. & Owens, D. The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetes. Diabetes Technol. Ther. 13, 813-818 (2011).
18. [No authors listed] Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. The DCCT Research Group. Am. J. Med. 90, 450-459 (1991).
19. [No authors listed] The effect of intensive insulin treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N. Engl. J. Med. 329, 977-986 (1993).
20. [No authors listed] Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group. Diabetes 46, 271-286 (1997).
21. MacLeod, K. M., Hepburn, D. A. & Frier, B. M. Frequency and morbidity of severe hypoglycaemia in insulin-treated diabetic patients. Diabet. Med. 10, 238-245 (1993).
22. [No authors listed] Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 37, 278-285 (1994).
23. ter Braak, E. W. et al. Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care 23, 1467-1471 (2000).
24. UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 50, 1140-1147 (2007).
25. Leiter, L. A. et al. Assessment of the impact of fear of hypoglycemic episodes on glycemic and hypoglycemia management. Can. J. Diabetes 29, 186-192 (2005).
26. Mühlhauser, I., Overmann, H., Bender, R., Bott, U. & Berger, M. Risk factors of severe hypoglycaemia in adult patients with type 1 diabetes-a prospective population based study. Diabetologia 41, 1274-1282 (1998).
27. Kristensen, P. L. et al. Insulin analogues and severe hypoglycaemia in type 1 diabetes. Diabetes Res. Clin. Pract. 96, 17-23 (2012).
28. Pedersen-Bjergaard, U., Agerholm-Larsen, B., Pramming, S., Hougaard, P. & Thorsteinsson, B. Prediction of severe hypoglycaemia by angiotensin-converting enzyme activity and genotype in type 1 diabetes. Diabetologia 46, 89-96 (2003).
29. [No authors listed] Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group. Diabetes Care 10, 1-19 (1987).
30. Nielsen, L. R. et al. Hypoglycemia in pregnant women with type 1 diabetes: predictors and role of metabolic control. Diabetes Care 31, 9-14 (2008).
31. Hepburn, D. A., MacLeod, K. M., Pell, A. C., Scougal, I. J. & Frier, B. M. Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin. Diabet. Med. 10, 231-237 (1993).
32. Henderson, J. N., Allen, K. V., Deary, I. J. & Frier, B. M. Hypoglycaemia in insulin-treated type 2 diabetes: frequency, symptoms and impaired awareness. Diabet .Med. 20, 1016-1021 (2003).
33. Allen, K. V. & Frier, B. M. Nocturnal hypoglycemia: clinical manifestations and therapeutic strategies toward prevention. Endocr. Pract. 9, 530-543 (2003).
34. Chow, E. & Heller, S. R. in Hypoglycaemia in Clinical Diabetes 3rd edn Ch. 5 (eds Frier, B. M., Heller, S. R. & McCrimmon, R. J.) 96-113 (Wiley Blackwell, 2014).
35. Schütt, M. et al. Multiple complications and frequent severe hypoglycaemia in 'elderly' and 'old' patients with type 1 diabetes. Diabet. Med. 29, e176-e179 (2012).
36. Matyka, K. A. in Hypoglycaemia in Clinical Diabetes 3rd edn Ch. 10 (eds Frier, B. M., Heller, S. R. & McCrimmon, R. J.) 197-217 (Wiley Blackwell, 2014).
37. Zammitt, N. N. & Frier, B. M. in Hypoglycaemia in Clinical Diabetes 3rd edn Ch. 12 (eds Frier, B. M., Heller, S. R. & McCrimmon, R. J.) 230-262 (Wiley Blackwell, 2014).
38. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N. Engl. J. Med. 358, 2545-2559 (2008).
39. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 358, 2560-2572 (2008).
40. Duckworth, W. et al. Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl. J. Med. 360, 129-139 (2009).
41. Ryder, R. E., Owens, D. R., Hayes, T. M., Ghatei, M. A. & Bloom, S. R. Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relation with diabetic autonomic neuropathy. BMJ 301, 783-787 (1990).
42. Graveling, A. J. & Frier, B. M. Impaired awareness of hypoglycaemia: a review. Diabetes Metab. 36 (Suppl. 3), S64-S74 (2010).
43. Cryer, P. E. Mechanisms of hypoglycemia-associated autonomic failure in diabetes. N. Engl. J. Med. 369, 362-372 (2013).
44. White, N. H. et al. Identification of type 1 diabetic patients at increased risk for hypoglycemia during intensive therapy. N. Engl. J. Med. 308, 485-491 (1983).
45. Gold, A. E., MacLeod, K. M. & Frier, B. M. Frequency of severe hypoglycemia in patients with impaired awareness of hypoglycemia. Diabetes Care 17, 697-703 (1994).
46. Geddes, J., Schopman, J. E., Zammitt, N. N. & Frier, B. M. Prevalence of impaired awareness of hypoglycaemia in adults with type 1 diabetes. Diabet. Med. 25, 501-504 (2008).
47. Schopman, J. E., Geddes, J. & Frier, B. M. Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated type 2 diabetes. Diabetes Res. Clin. Pract. 87, 64-68 (2010).
48. Mühlhauser, I., Toth, G., Sawicki, P. T. & Berger, M. Severe hypoglycemia in type I diabetic patients with impaired kidney function. Diabetes Care 14, 344-346 (1991).
49. Davis, T. M. et al. Determinants of severe hypoglycemia complicating type 2 diabetes: the Fremantle diabetes study. J. Clin. Endocrinol. Metab. 95, 2240-2247 (2010).
50. Gold, A. E., Frier, B. M., MacLeod, K. M. & Deary, I. J. A structural equation model for predictors of severe hypoglycaemia in patients with insulin-dependent diabetes mellitus. Diabet. Med. 14, 309-315 (1997).
51. Punthakee, Z. et al. Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care 35, 787-793 (2012).
52. Faerch, L., Pedersen-Bjergaard, U. & Thorsteinsson, B. High serum ACE activity predicts severe hypoglycaemia over time in patients with type 1 diabetes. Scand. J. Clin. Lab. Med. 71, 620-624 (2011).
53. Bulsara, M. K. et al. The relationship between ACE genotype and risk of severe hypoglycaemia in a large population-based cohort of children and adolescents with type 1 diabetes. Diabetologia 50, 965-971 (2007).
54. Zammitt, N. N. et al. Serum angiotensin-converting enzyme and frequency of severe hypoglycaemia in type 1 diabetes: does a relationship exist? Diabet. Med. 24, 1449-1454 (2007).
55. McAulay, V., Deary, I. J. & Frier, B. M. Symptoms of hypoglycaemia in people with diabetes. Diabet. Med. 18, 690-705 (2001).
56. McCrimmon, R. J., Frier, B. M. & Deary, I. J., Appraisal of mood and personality during hypoglycaemia in human subjects. Physiol. Behav. 67, 27-33 (1999).
57. Inkster, B. & Frier, B. M. The effects of acute hypoglycaemia on cognitive function in type 1 diabetes. Br. J. Diabetes Vasc. Dis. 12, 221-226 (2012).
58. Inkster, B. & Frier, B. M. Driving and diabetes. Diabetes Obes. Metab. 15, 775-783 (2013).
59. Graveling, A. J. & Frier, B. M. Hypoglycaemia: an overview. Prim. Care Diabetes 3, 131-139 (2009).
60. Frier, B. M. How hypoglycaemia can affect the life of a person with diabetes. Diabetes Metab. Res. Rev. 24, 87-92 (2008).
61. Frier, B. M. in Hypoglycaemia in Clinical Diabetes 3rd edn Ch. 18 (eds Frier, B. M., Heller, S. R. & McCrimmon, R. J.) 347-368 (Wiley Blackwell, 2014).
62. Wild, D. et al. A critical review of the literature on fear of hypoglycemia in diabetes: implications for diabetes management and patient education. Patient Educ. Couns. 68, 10-15 (2007).
63. Barendse, S., Singh, H., Frier, B. M. & Speight, J. The impact of hypoglycaemia on quality of life and related patient-reported outcomes in type 2 diabetes: a narrative review. Diabet. Med. 29, 293-302 (2012).
64. Leckie, A. M., Graham, M. K., Grant, J. B., Ritchie, P. J. & Frier, B. M. Frequency, severity, and morbidity of hypoglycemia occurring in the workplace in people with insulin-treated diabetes. Diabetes Care 28, 1333-1338 (2005).
65. Brod, M., Rana, A. & Barnett, A. H. Impact of self-treated hypoglycaemia in type 2 diabetes: a multinational survey in patients and physicians. Curr. Med. Res. Opin. 28, 1-12 (2012).
66. Lawton, J. et al. Experiences, views, and support needs of family members of people with hypoglycemia unawareness: interview study. Diabetes Care 37, 109-115 (2014).
67. Wright, R. J. & Frier, B. M. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab. Res. Rev. 24, 353-363 (2008).
68. Sommerfield, A. J., Wilkinson, I. B., Webb, D. J. & Frier, B. M. Vessel wall stiffness in type 1 diabetes, and the central hemodynamic effects of acute hypoglycemia. Am. J. Physiol. Endocrinol. Metab. 293, E1274-E1279 (2007).
69. Rana, O. et al. Acute hypoglycemia decreases myocardial blood flow reserve in patients with type 1 diabetes mellitus and in healthy humans. Circulation 124, 1548-1556 (2011).
70. Lindström, T., Jorfeldt, L., Tegler, L. & Arnqvist, H. J. Hypoglycaemia and cardiac arrhythmias in patients with type 2 diabetes mellitus. Diabet. Med. 9, 536-541 (1992).
71. Desouza, C., Salazar, H., Cheong, B., Murgo, J. & Fonseca, V. Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring. Diabetes Care 26, 1485-1489 (2003).
72. Koivikko, M. L. et al. Effects of controlled hypoglycaemia on cardiac repolarisation in patients with type 1 diabetes. Diabetologia 51, 426-435 (2008).
73. Robinson, R. T. et al. Mechanisms of abnormal cardiac repolarisation during insulin-induced hypoglycemia. Diabetes 52, 1469-1474 (2003).
74. Gill, G. V., Woodward, A., Casson, I. F. & Weston, P. J. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes-the 'dead in bed' syndrome revisited. Diabetologia 52, 42-45 (2009).
75. Stahn, A. et al. Relationship between hypoglycemic episodes and ventricular arrhythmias in patients with type 2 diabetes and cardiovascular diseases: silent hypoglycemias and silent arrhythmias. Diabetes Care 37, 516-520 (2014).
76. Chow, E. et al. Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk. Diabetes 63, 1738-1747 (2014).
77. Jones, T. W. et al. Decreased epinephrine responses to hypoglycemia during sleep. N. Engl. J. Med. 338, 1657-1662 (1998).
78. Reno, C. M. et al. Severe hypoglycemia-induced lethal cardiac arrhythmias are mediated by sympathoadrenal activation. Diabetes 62, 3570-3581 (2013).
79. Lee, S. P. et al. Influence of autonomic neuropathy on QTc interval lengthening during hypoglycemia in type 1 diabetes. Diabetes 53, 1535-1542 (2004).
80. Soydan, N. et al. Reduced capacity of heart rate regulation in response to mild hypoglycemia induced by glibenclamide and physical exercise in type 2 diabetes. Metabolism 62, 717-724 (2013).
81. Tattersall, R. B. & Gill, G. V. Unexplained deaths of type 1 diabetic patients. Diabet. Med. 8, 49-58 (1991).
82. Tanenberg, R. J., Newton, C. A. & Drake, A. J. Confirmation of hypoglycemia in the 'dead-in-bed' syndrome as captured by a retrospective continuous glucose monitoring system. Endocr. Pract 16, 244-248 (2010).
83. Tsujimoto, T. et al. Vital signs, QT prolongation, and newly diagnosed cardiovascular disease during severe hypoglycemia in type 1 and type 2 diabetic patients. Diabetes Care 37, 217-225 (2014).
84. Frier, B. M. & Hilsted, J. Does hypoglycaemia aggravate the complications of diabetes? Lancet 326, 1175-1177 (1985).
85. Giminez, M. et al. Repeated episodes of hypoglycemia as a potential aggravating factor for preclinical atherosclerosis in subjects with type 1 diabetes. Diabetes Care 34, 198-203 (2011).
86. Wright, R. J. et al. Effects of acute insulin-induced hypoglycemia on indices of inflammation. Diabetes Care 33, 1591-1597 (2010).
87. Chow, E. Y. K., Iqbal, A., Phoenix, F., Heller, S. R. & Ajjan, R. A. Hypoglycaemia promotes thrombosis and inflammation for at least one week in patients with type 2 diabetes [abstract]. Diabetologia 56 (Suppl. 1), S243 (2013).
88. Robinson, A. M. et al. Antecedent hypoglycaemia in non-diabetic subjects reduces the adrenaline response for 6 days but does not affect the catecholamine response to other stimuli. Clin. Sci. (Lond.) 89, 359-366 (1995).
89. Adler, G. K. et al. Antecedent hypoglycemia impairs autonomic cardiovascular function. Implications for rigorous glycemic control. Diabetes 58, 360-366 (2009).
90. Heusch, G. et al. Cardiovascular remodelling in coronary artery disease and heart failure. Lancet 383, 1933-1943 (2014).
91. Schernthaner, G. Diabetes and cardiovascular disease: is intensive glucose control beneficial or deadly? Lessons from ACCORD, ADVANCE, VADT, UKPDS, PROactive, and NICE-SUGAR. Wien. Med. Wochenschr. 160, 8-19 (2010).
92. Frier, B. M., Schernthaner, G. & Heller, S. R. Hypoglycemia and cardiovascular risks. Diabetes Care 34 (Suppl. 2), S132-S137 (2011).
93. Bonds, D. E. et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ 340, b4909 (2010).
94. ORIGIN Trial Investigators. Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN Trial. Eur. Heart J. 34, 3137-3144 (2013).
95. Leese, G. P. et al. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes. A population-based study of health service resource use. Diabetes Care 26, 1176-1180 (2003).
96. Warren, R. E. & Frier, B. M. Hypoglycaemia and cognitive function. Diabetes Obes. Metab. 7, 493-503 (2005).
97. Zammitt, N. N., Warren, R. E., Deary, I. J. & Frier, B. M. Delayed recovery of cognitive function following hypoglycemia in adults with type 1 diabetes. Effect of impaired awareness of hypoglycemia. Diabetes 57, 732-736 (2008).
98. Bjorgaas, M., Sand, T., Vik, T. & Jorde, R. Quantitative EEG during controlled hypoglycaemia in diabetic and nondiabetic children. Diabet. Med. 15, 30-37 (1998).
99. Perros, P. & Bjorgaas, M. in Hypoglycaemia in Clinical Diabetes 3rd edn Ch. 15 (eds Frier, B. M., Heller, S. R. & McCrimmon, R. J.) 305-322 (Wiley Blackwell, 2014).
100. Tallroth, G., Ryding, E. & Agardh, C. D. Regional cerebral blood flow in normal man during insulin-induced hypoglycemia and in the recovery period following glucose infusion. Metabolism 41, 717-721 (1992).
101. Kennan, R. P., Takahashi, K., Pan, C., Shamoon, H. & Pan, J. W. Human cerebral blood flow and metabolism in acute insulin-induced hypoglycemia. J. Cereb. Blood Flow Metab. 25, 527-534 (2005).
102. MacLeod, K. M. et al. Regional cerebral blood flow in IDDM patients: effects of diabetes and of recurrent severe hypoglycaemia. Diabetologia 37, 257-263 (1994).
103. MacLeod, K. M. et al. The effects of acute hypoglycemia on relative cerebral blood flow distribution in patients with type 1 (insulin-dependent) diabetes and impaired hypoglycemia awareness. Metabolism 45, 974-980 (1996).
104. Chalmers, J. et al. Severe amnesia after hypoglycemia. Clinical, psychometric, and magnetic resonance imaging correlates. Diabetes Care 14, 922-925 (1991).
105. Bottcher, J. et al. Localized reversible reduction of apparent diffusion coefficient in transient hypoglycemia-induced hemiparesis. Stroke 36, e20-e22 (2005).
106. Cordonnier, C. et al. Serial diffusion and perfusion-weighted MR in transient hypoglycemia. Neurology 65, 175 (2005).
107. Arbelaez, A. M. & Hershey, T. Imaging hypoglycemia's effects on the human brain. Diabetic Hypoglycemia 3, 3-9 (2010).
108. Asvold, B. O., Sand, T., Hestad, K. & Bjorgaas, M. R. Cognitive function in type 1 diabetic adults with childhood exposure to severe hypoglycemia: a 16 year follow-up study. Diabetes Care 33, 1945-1947 (2010).
109. Ly, T. T., Anderson, M., McNamara, K. T., Davis, E. A. & Jones, T. W. Neurocognitive outcomes in young adults with early-onset type 1 diabetes. Diabetes Care 34, 2192-2197 (2011).
110. Northam, E. A. et al. Central nervous system function in youth with type 1 diabetes 12 years after disease onset. Diabetes Care 32, 445-450 (2009).
111. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. Long-term effect of diabetes and its treatment on cognitive function. N. Engl. J. Med. 356, 1842-1852 (2007).
112. Biessels, G. J. Hypoglycemia and cognitive decline in older people with type 2 diabetes: a bidirectional relationship. Diabetic Hypoglycemia 6, 11-14 (2014).
113. Yaffe, K. et al. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern. Med. 173, 1300-1306 (2013).
114. Feinkohl, I. et al. Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care 37, 507-515 (2014).
115. Ryan, C. M. in Hypoglycaemia in Clinical Diabetes 3rd edn Ch. 14 (eds Frier, B. M., Heller, S. R. & McCrimmon, R. J.) 285-304 (Wiley Blackwell, 2014).
116. Seaquist, E. R. et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 36, 1384-1395 (2013).
117. Cox, D. J., Gonder-Frederick, L., Ritterband, L., Clarke, W. & Kovatchev, B. P. Prediction of severe hypoglycemia. Diabetes Care 30, 1370-1373 (2007).
118. Siebenhofer, A. et al. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD003287. http://dx.doi.org/10.1002/14651858.CD003287.pub4.
119. Horvath, K. et al. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews. Issue 2. Art. No.: CD005613. http://dx.doi.org/10.1002/14651858.CD005613.pub3.
120. Inkster, B., Zammitt, N. N. & Frier, B. M. Drug-induced hypoglycaemia in type 2 diabetes. Expert Opin. Drug Saf. 11, 597-614 (2012).
121. Buckingham, B. et al. Response to nocturnal alarms using a real-time glucose sensor. Diabetes Technol. Ther. 7, 440-447 (2005).
122. Choudhary, P. et al. Real-time continuous glucose monitoring significantly reduces severe hypoglycemia in hypoglycemia-unaware patients with type 1 diabetes. Diabetes Care 36, 4160-4162 (2013).
123. Hanaire, H. et al. Treatment of diabetes mellitus using an external insulin pump: the state of the art. Diabetes Metab. 34, 401-423 (2008).
124. Pickup, J. C. & Sutton, A. J. Severe hypoglycaemia and glycaemic control in type 1 diabetes; meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet. Med. 25, 765-774 (2008).
125. Hovorka, R. Closed-loop insulin delivery: from bench to clinical practice. Nat. Rev. Endocrinol. 7, 385-395 (2011).
126. Renard, E., Cobelli, C. & Kovatchev, B. P. Closed loop developments to improve glucose control at home. Diabetes Res. Clin. Pract. 102, 79-85 (2013).
127. Ly, T. T. et al. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes. A randomized clinical trial. JAMA 310, 1240-1247 (2013).
128. Bergenstal, R. M. et al. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N. Engl. J. Med. 369, 224-232 (2013).